EvaxionEVAX
Fair Value
US$19.75
Share price06 Jan
US$3.283.8% undervalued intrinsic discount
1Y29.55%
7D-5.33%
AI Immunology Partnerships And Pipeline Progress Will Drive Long Term Value
AN
Analyst High Target compiles bullish analysts opinions to create narratives which represent one standard deviation above the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls
Published
06 Jan 26
Views
24
Not Invested